The previous page is sending you to https://www.businesswire.com/news/home/20190408005220/en/Applied-DNA-Subsidiary-LineaRx-Achieves-Biotech-Industry-First-with-Anti-CD19-Expression-in-Human-CAR-T-Cells-via-Proprietary-Non-Viral-Plasmid-Free-Platform.

 If you do not want to visit that page, you can return to the previous page.